# FMC Corp: Form 10-Q for the period ended Jun 30, 2014

- Company: [FMC Corp](/companies/fmc.md) (CIK 37785)
- Form: 10-Q
- Filed: 2014-08-01
- Accepted by EDGAR: Aug 1, 2014, 18:44 ET
- Period: 2014-06-30
- Accession: 0000037785-14-000035
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/37785/000003778514000035/fmc630201410q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/37785/000003778514000035/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2014-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2014-04-01 to 2014-06-30 | $987.8m | us-gaap:Revenues |
| Revenue | 6 months, 2014-01-01 to 2014-06-30 | $1.93bn | us-gaap:Revenues |
| Cost of revenue | 3 months, 2014-04-01 to 2014-06-30 | $630.2m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months, 2014-01-01 to 2014-06-30 | $1.24bn | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2014-04-01 to 2014-06-30 | $357.6m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2014-01-01 to 2014-06-30 | $686.1m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2014-04-01 to 2014-06-30 | $125.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2014-01-01 to 2014-06-30 | $244.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2014-04-01 to 2014-06-30 | $182.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2014-01-01 to 2014-06-30 | $356.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2014-04-01 to 2014-06-30 | $41.5m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2014-01-01 to 2014-06-30 | $80.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2014-04-01 to 2014-06-30 | $109.1m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2014-01-01 to 2014-06-30 | $174.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2014-04-01 to 2014-06-30 | $0.81 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2014-01-01 to 2014-06-30 | $1.30 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2014-04-01 to 2014-06-30 | $0.82 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2014-01-01 to 2014-06-30 | $1.31 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2014-04-01 to 2014-06-30 | 134,354,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2014-01-01 to 2014-06-30 | 134,277,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2014-01-01 to 2014-06-30 | $148.5m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 6 months, 2014-01-01 to 2014-06-30 | $120.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months, 2014-01-01 to 2014-06-30 | $38.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months, 2014-01-01 to 2014-06-30 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2014-06-30 | $114.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2014-06-30 | $2.75bn | us-gaap:AssetsCurrent |
| Total assets | at 2014-06-30 | $5.13bn | us-gaap:Assets |
| Current liabilities | at 2014-06-30 | $1.69bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2014-06-30 | $1.15bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2014-06-30 | $18.9m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | at 2014-06-30 | $525.3m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2014-06-30 | $1.71bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2014-06-30 | 133,241,113 shares | dei:EntityCommonStockSharesOutstanding |

## Management's discussion and analysis

As filed, 54,207 characters.

Item 2 of this report contains certain forward-looking statements that are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information.

Whenever possible, we have identified these forward-looking statements by such words or phrases as “will likely result”, “is confident that”, "expect", “expects”, “should”, “could”, “may”, “will continue to”, "believe", “believes”, “anticipates”, “predicts”, “forecasts”, “estimates”, “projects”, “potential”, “intends” or similar expressions identifying “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. The forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. These statements are qualified by reference to the section “Forward-Looking Statements” in Part II of our Annual Report on Form 10-K for the year ended December 31, 2013 (the “2013 10-K”) and to similar disclaimers in all other reports and forms filed with the Securities and Exchange Commission (“SEC”). We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made.

We further caution that the list of risk factors in Item 1A in Part I of the 2013 10-K may not be all-inclusive, and we specifically decline to undertake any obligation to publicly revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

### APPLICATION OF CRITICAL ACCOUNTING POLICIES

Our consolidated financial statements are prepared in conformity with U.S. generally accepted accounting principles. The preparation of our financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We have described our accounting policies in Note 1 to our consolidated financial statements included in our 2013 10-K. We have reviewed these accounting policies, identifying those that we believe to be critical to the preparation and understanding of our consolidated financial statements. We have reviewed these critical accounting policies with the Audit Committee of our Board of Directors. Critical accounting policies are central to our presentation of results of operations and financial condition and require management to make estimates and judgments on certain matters. We base our estimates and judgments on historical experience, current conditions and other reasonable factors.

The following is a list of those accounting policies that we have deemed most critical to the presentation and understanding of our results of operations and financial condition. See the “Application of Critical Accounting Policies” section in our 2013 10-K for a detailed description of these policies and their potential effects on our results of operations and financial condition.

- Environmental obligations and related recoveries
- Impairment and valuation of long-lived assets
- Pensions and other postretirement benefits
- Income taxes

We did not adopt any changes in the current period that had a material effect on these critical accounting policies nor did we make any changes to our accounting policies that would have changed these critical accounting policies.

### RECENTLY ISSUED AND ADOPTED ACCOUNTING PRONOUNCEMENTS AND REGULATORY ITEMS

See Note 2 to our condensed consolidated financial statements included in this Form 10-Q for a discussion of recently adopted accounting guidance and other new accounting guidance.

### OVERVIEW

We are a diversified chemical company serving agricultural, consumer and industrial markets globally with innovative solutions, applications and market-leading products. We operate in three distinct business segments: FMC Agricultural Solutions, FMC Health and Nutrition and FMC Minerals. Our FMC Agricultural Solutions segment develops, markets and sells all three major classes of crop protection chemicals – insecticides, herbicides and fungicides. These products are used in agriculture to enhance crop yield and quality by controlling a broad spectrum of insects, weeds and disease, as well as in non-agricultural markets for pest control. The FMC Health and Nutrition segment focuses on food, pharmaceutical ingredients, nutraceuticals, personal care and similar markets. Our food ingredients are used to enhance texture, color, structure and physical stability. The pharmaceutical additives are used for binding, encapsulation and disintegrant applications. Our FMC Minerals segment manufactures a wide range of inorganic materials, including soda ash and lithium. Soda ash is utilized in markets such as glass and detergents and lithium is utilized in energy storage, specialty polymers and pharmaceutical synthesis.

### Second Quarter 2014 Highlights

The following are the more significant developments in our businesses during the three months ended June 30, 2014:

- Revenue of $987.8 million for the three months ended June 30, 2014 increased $111.8 million or 13 percent versus the same period last year. The increase in revenue was driven by all three of our segments. A more detailed review of revenues by segment is discussed under the section titled "Results of Operations". On a regional basis, sales in North America increased by 11 percent, sales in Asia were up 20 percent, Latin America sales increased by seven percent and sales in Europe, Middle East and Africa were up 18 percent.
- Our gross margin, excluding acquisition related charges, increased by approximately $31 million or approximately 10 percent to $358.7 million versus prior year's quarter. Gross margin percent of 36 percent declined from 37 percent. The reduction in gross margin and gross margin percent was driven by unfavorable currency movements and product mix of sales in FMC Agricultural Solutions.
- Selling, general and administrative expenses, excluding non-operating pension and postretirement charges increased by approximately $7 million or six percent to $122.3 million. The majority of these increases were experienced in our FMC Agricultural Solutions segment.
- Research and Development expenses of $33.2 million increased approximately $6 million or 20 percent. This increase is primarily related to spending in FMC Agricultural Solutions to fund investments in earlier stage active ingredient research, biological crop protection development projects and rapid market innovation initiatives.
- Adjusted after-tax earnings from continuing operations attributable to FMC stockholders of $135.7 million increased $7.8 million or 6 percent primarily due to higher operating results in FMC Agricultural Solutions, FMC Health and Nutrition and FMC Minerals. See the disclosure of our Adjusted Earnings Non-GAAP financial measurement below, under the section titled "Results of Operations".

### Other Highlights

- On March 10, 2014, we announced a plan to separate into two independent public companies. One company initially referred to as “New FMC,” will contain our FMC Agricultural Solutions and FMC Health and Nutrition segments, while the other company, "FMC Minerals", will be comprised of our FMC Minerals segment. “New FMC” will be renamed "FMC Corporation" subsequent to the separation. During the second quarter we incurred $13.8 million in business separation costs as we continued to separate into two independent public companies.

### RESULTS OF OPERATIONS

### Overview

The following presents a reconciliation of our segment operating profit to the net income attributable to FMC stockholders as seen through the eyes of our management. For management purposes, we report the operating performance of each of our business segments based on earnings before interest and income taxes excluding corporate expenses, other income (expense), net and corporate special income/(charges).

*SEGMENT RESULTS RECONCILIATION*

*(in Millions)*

| 2014 Revenue | Three Months Ended June 30 | 2013 | Six Months Ended June 30 2014 | 2013 |
| --- | ---: | ---: | ---: | ---: |
| FMC Agricultural Solutions | $531.2 | $442.6 | $998.1 | $937.8 |
| FMC Health and Nutrition | 207.1 | 189.9 | 433.3 | 381.8 |
| FMC Minerals | 249.6 | 244.4 | 498.3 | 469.0 |
| Eliminations | (0.1) | (0.9) | (0.1) | (1.9) |
| Total | $987.8 | $876.0 | $1,929.6 | $1,786.7 |
| **Income (loss) from continuing operations before income taxes** |  |  |  |  |
| FMC Agricultural Solutions | $130.7 | $124.7 | $250.8 | $288.0 |
| FMC Health and Nutrition | 49.1 | 44.3 | 100.0 | 88.0 |
| FMC Minerals | 42.8 | 35.4 | 79.6 | 64.4 |
| Eliminations | — | (0.1) | — | (0.2) |
| **Segment operating profit** | $222.6 | $204.3 | $430.4 | $440.2 |
| Corporate and other | (19.6) | (20.3) | (37.1) | (40.1) |
| **Operating profit before the items listed below** | $203.0 | $184.0 | $393.3 | $400.1 |
| Interest expense, net | (15.3) | (11.1) | (28.8) | (21.6) |
| Corporate special (charges) income: |  |  |  |  |
| Restructuring and other (charges) income (1) | (2.7) | (5.9) | (9.4) | (15.2) |
| Non-operating pension and postretirement charges (2) | (2.7) | (11.6) | (6.9) | (24.3) |
| Business separation costs (3) | (13.8) | — | (16.8) | — |
| Acquisition related charges (4) | (1.1) | — | (4.2) | — |
| Provision for income taxes | (41.5) | (35.7) | (80.8) | (81.1) |
| Discontinued operations, net of income taxes | (12.6) | 1.5 | (62.7) | (1.7) |
| Net income attributable to noncontrolling interests | (4.2) | (3.2) | (9.0) | (7.3) |
| **Net income attributable to FMC stockholders** | $109.1 | $118.0 | $174.7 | $248.9 |

(1) See Note 7 for details of restructuring and other charges (income). Amounts for the three months ended June 30, 2014, relate to FMC Health and Nutrition of $1.0 million, FMC Minerals of $(0.1) million and Corporate of $1.8 million. Amounts for the three months ended June 30, 2013, relate to FMC Agricultural Solutions of $1.4 million, FMC Minerals of $3.5 million, and Corporate of $1.0 million. Amounts for the six months ended June 30, 2014, relate to FMC Health and Nutrition of $5.9 million and Corporate of $3.5 million. Amounts for the six months ended June 30, 2013, relate to FMC Agricultural Solutions of $2.0 million, FMC Health and Nutrition of $0.6 million, FMC Minerals of $9.3 million and Corporate of $3.3 million.

(2) Our non-operating pension and postretirement costs are defined as those costs related to interest, expected return on plan assets, amortized actuarial gains and losses and the impacts of any plan curtailments or settlements. These costs are primarily related to changes in pension plan assets and liabilities which are tied to financial market performance and we consider these costs to be outside our operational performance. We exclude these non-operating pension and postretirement costs from our segments as we believe that removing them provides a better understanding of the underlying profitability of our businesses, provides increased transparency and clarity in the performance of our retirement plans and enhances period-over-period comparability. We continue to include the service cost and amortization of prior service cost in our operating segments noted above. We believe these elements reflect the current year operating costs to our businesses for the employment benefits provided to active employees. These expenses are included as a component of the line item “Selling, general and administrative expenses” on our condensed consolidated statements of income.

(3) Charges are associated with our announced plan to separate into two independent public companies. See Note 3 in our condensed consolidated financial statements filed in this Form 10-Q for more detail on the business separation costs. These charges are included within "Business separation costs" on our condensed consolidated income statement. These costs were primarily related to professional fees associated with separation activities within the finance and legal functions.

(4) Charges relate to the expensing of the inventory fair value step-up resulting from the application of purchase accounting for acquisitions and costs incurred associated the completion of acquisitions. On the condensed consolidated statements of income, the charges associated with inventory fair value step-up are included in “Costs of sales and services” and fees associated with concluding the acquisitions are included in "Selling, general and administrative expenses". Charges for the three and six months ended June 30, 2014, represented amortization of inventory fair value step-up associated with our Epax acquisition completed in the latter part of 2013 within our FMC Health and Nutrition segment, see Note 3 to our 2013 10-K for more information.

The following chart, which is provided to assist the readers of our financial statements, depicts certain after-tax charges (gains). These items are excluded by us in the measures we use to evaluate business performance and determine certain performance-based compensation. These after-tax items are discussed in detail within the “Other results of operations” section that follows. Additionally, the chart below discloses our Non-GAAP financial measure “Adjusted after-tax earnings from continuing operations attributable to FMC stockholders” reconciled from the GAAP financial measure “Net income attributable to FMC stockholders”. We believe that this measure provides useful information about our operating results to investors and securities analysts. We also believe that excluding the effect of restructuring and other income and charges, non-operating pension and postretirement charges, certain tax adjustments from operating results and discontinued operations allows management and investors to compare more easily the financial performance of our underlying businesses from period to period. This measure should not be considered as a substitute for net income (loss) or other measures of performance or liquidity reported in accordance with GAAP.

*ADJUSTED EARNINGS RECONCILIATION*

*(in Millions)*

| 2014 | Three Months Ended June 30 | 2013 | Six Months Ended June 30 2014 | 2013 |
| --- | ---: | ---: | ---: | ---: |
| **Net income attributable to FMC stockholders (GAAP)** | $109.1 | $118.0 | $174.7 | $248.9 |
| Corporate special charges (income), pre-tax | 20.3 | 17.5 | 37.3 | 39.5 |
| Income tax expense (benefit) on Corporate special charges (income) | (7.3) | (6.8) | (13.1) | (14.9) |
| Corporate special charges (income), net of income taxes | $13.0 | $10.7 | $24.2 | $24.6 |
| Discontinued operations, net of income taxes | 12.6 | (1.5) | 62.7 | 1.7 |
| Tax adjustments | 1.0 | 0.7 | 1.0 | 1.7 |
| **Adjusted after-tax earnings from continuing operations attributable to FMC stockholders (Non-GAAP)** | $135.7 | $127.9 | $262.6 | $276.9 |

In the discussion below, please refer to our chart titled "Segment Results Reconciliation" within the Results of Operations section. All comparisons are between the periods unless otherwise noted.

### Segment Results

For management purposes, segment operating profit is defined as segment revenue less operating expenses (segment operating expenses consist of costs of sales and services, selling, general and administrative expenses and research and development expenses). We have excluded the following items from segment operating profit: corporate staff expense, interest income and expense associated with corporate debt facilities and investments, income taxes, gains (or losses) on divestitures of businesses, restructuring and other charges (income), non-operating pension and postretirement charges, investment gains and losses, loss on extinguishment of debt, asset impairments, Last-in, First-out ("LIFO") inventory adjustments, acquisition related charges, and other income and expense items.

Information about how each of these items relates to our businesses at the segment level and results by segment is discussed in Note 19 of our condensed consolidated financial statements filed in this Form 10-Q and in Note 20 of our consolidated financial statements in our 2013 Form 10-K.

### FMC Agricultural Solutions

*($ in Millions)*

| 2014 | Three Months Ended June 30 | 2013 | Six Months Ended June 30 2014 | 2013 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $531.2 | $442.6 | $998.1 | $937.8 |
| Operating Profit | 130.7 | 124.7 | 250.8 | 288.0 |

### Three Months Ended June 30, 2014 vs. 2013

Revenue of $531.2 million increased approximately 20 percent versus the prior year quarter due to increased sales across all regions.

In Latin America, sales were $202.7 million up 10 percent, driven by expanded market access and higher sales of third party products in the region; these sales were partially offset by poor conditions that impacted sugarcane plantings in Brazil and reduced demand for herbicides and insecticides. In North America, sales were $168.6 million, up 27 percent , due to the prolonged cold weather that resulted in a shift in timing of sales into the second quarter. Sales in Europe, Middle East and Africa (EMEA) increased 46 percent to $62.3 million driven by higher herbicide volumes. Asian sales were $97.6 million, up 17 percent, reflecting sales growth in Australia, Pakistan, Korea and China.

FMC Agricultural Solutions' operating profit of $130.7 million increased approximately five percent compared to the prior-year quarter, reflecting the sales increases described in the preceding paragraph. Segment operating profit margin was impacted by changes in product mix, unfavorable foreign exchange movements and planned increases to selling, general and administrative (S,G&A) costs as well as research and development (R&D). S,G&A costs were approximately $7 million higher and R&D costs were approximately $6 million higher than the prior-year quarter with spending focused on sales and technology investments.

### Six Months Ended June 30, 2014 vs. 2013

Revenue of $998.1 million increased approximately six percent versus the prior year period due to sales growth across all regions despite unfavorable weather conditions during the first half of the year.

Latin America sales of $343.1 million increased one percent. North America sales of $389.2 million increased eight percent and EMEA sales of $87.6 million increased nine percent. Revenue in Asia of $178.2 million increased 12 percent mainly reflecting sales growth in Australia, India, Pakistan and China.

FMC Agricultural Solutions' operating profit of $250.8 million decreased approximately 13 percent compared to the year-ago period, reflecting unfavorable currency impacts, planned increases to S,G&A as well as R&D costs and weather-related changes in product mix. S,G&A costs were approximately $12 million higher and R&D costs were approximately $4 million higher than the prior-year period with spending on marketing, sales and technology investments.

In 2014, we expect full-year segment revenue to grow mid- to high- single digits percentage reflecting increased volumes and growth from new and recently introduced products, particularly in Latin America and Europe. We expect full-year segment operating profit growth in the mid-single digits percentage driven primarily by continued market share gain in Latin America partially offset by the drought conditions affecting sugarcane in Brazil.

#### Certain Regulatory Issues

We intend to defend vigorously all our products in the U.S., EU and other countries as our pesticide products are reviewed in the ordinary course of regulatory programs during 2014 as part of the ongoing cycle of re-registration of our pesticide products around the world. In early 2014, the Brazilian health surveillance agency informed us that they intend to complete their review of carbofuran along with several other major pesticides by the end of this year, but the agency has not yet issued any required formal announcement that identifies their specific concerns or preliminary position on re-registration. We are co-operating and defending our product in this process. Under the Brazilian regulatory process, any recommendation would require public notice and comment as well as concurrence from the Brazilian environmental and agricultural ministries before any regulatory change is effective. Thus, we do not expect any material sales impact due to this Brazilian regulatory review during 2014.

### FMC Health and Nutrition

*($ in Millions)*

| 2014 | Three Months Ended June 30 | 2013 | Six Months Ended June 30 2014 | 2013 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $207.1 | $189.9 | $433.3 | $381.8 |
| Operating Profit | 49.1 | 44.3 | 100.0 | 88.0 |

### Three Months Ended June 30, 2014 vs. 2013

Revenue was $207.1 million, an increase of approximately nine percent versus the prior-year quarter. This revenue increase was due to higher sales into health markets, including revenue from acquisitions in 2013, slightly offset by weaker demand for nutrition products in Asia. Favorable price increases and currency contributed two percent, respectively, which were offset by lower volumes.

Segment operating profit of $49.1 million increased 11 percent versus the prior-year quarter primarily driven by the revenue growth discussed in the preceding paragraph and favorable mix of products.

### Six Months Ended June 30, 2014 vs. 2013

Revenue was $433.3 million, an increase of approximately 13 percent versus the prior-year period. Revenue from health markets, including that from acquisitions in 2013, increased sales by approximately 12 percent. The combination of favorable pricing, increased volumes and currency increased sales by one percent.

Segment operating profit of $100.0 million increased 14 percent versus the year ago period. The increase is consistent with that of the three months ended June 30, 2014 noted above.

In 2014, full year segment revenue is expected to increase low- to mid-teens percentage versus 2013 driven by higher volumes in texture and stability solutions, natural colors and binder product lines and contributions from the omega-3 product line. Full year segment operating profit is expected to grow mid-teens percentage versus 2013 due to increased demand for functional ingredients and benefits from new omega-3 sales.

### FMC Minerals

*($ in Millions)*

| 2014 | Three Months Ended June 30 | 2013 | Six Months Ended June 30 2014 | 2013 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $249.6 | $244.4 | $498.3 | $469.0 |
| Operating Profit | 42.8 | 35.4 | 79.6 | 64.4 |

### Three Months Ended June 30, 2014 vs. 2013

Revenue was $249.6 million, an increase of approximately two percent versus the prior-year quarter. Increased production in our Lithium division drove higher sales.

Lithium revenues of $56.6 million increased 11 percent. Improved operations produced additional volumes and allowed for higher sales, particularly for energy storage applications.

Alkali revenues of $193.0 million remained consistent with prior-year quarter revenue of $193.4 million. Higher pricing increased revenues by one percent. Lower volumes related to timing of shipments and lower freight associated with geographic mix reduced revenue by one percent.

Segment operating profit of $42.8 million increased approximately 21 percent versus the prior-year quarter. Higher volumes in Lithium and favorable pricing in Alkali improved profitability. Higher energy costs in Alkali were offset by continued progress in manufacturing cost improvements.

### Six Months Ended June 30, 2014 vs. 2013

Revenue was $498.3 million, an increase of approximately six percent versus the prior-year period. Volume gains in our Lithium division and improvements in soda ash pricing contributed to the higher revenue.

Lithium revenues of $120.4 million increased 27 percent due to higher production volumes that allowed for additional sales, particularly for energy storage applications.

Alkali revenues of $377.9 million increased one percent compared to the period year period. Higher average prices contributed two percent. Lower volumes related to timing of shipments and lower freight associated with geographic mix reduced sales by one percent. The most notable price increases were realized in Asian export markets.

Segment operating profit of $79.6 million increased approximately 24 percent versus the prior-year period. Operating profit was driven by higher volumes in Lithium and improved pricing in Alkali. These increases were partially offset by unfavorable currency and energy costs.

In 2014, we expect full-year segment revenue to grow mid- to high- single digits percentage driven primarily by increased volumes in both lithium and soda ash and short- and long-term contracted price increases in soda ash. Full-year segment operating profit in 2014 is expected to grow high-teens percentage versus the previous year, reflecting lithium margin improvements and more favorable soda ash pricing versus 2013.

### Other Results of Operations

#### Corporate and other

Corporate and other expenses are included as a component of the line item “Selling, general and administrative expenses” except for last-in, first-out (LIFO) related charges that are included as a component of "Cost of sales and services" on our condensed consolidated statements of income.

### Three Months Ended June 30, 2014 vs. 2013

Corporate and other expenses of $19.6 million in the second quarter of 2014 decreased slightly by $0.7 million from $20.3 million in the same period in 2013.

### Six Months Ended June 30, 2014 vs. 2013

Corporate and other expenses of $37.1 million in the first half of 2014 decreased by $3.0 million from $40.1 million in the same period in 2013. The decrease is partially driven by a reduction in our LIFO inventory reserve charge compared to prior period.

#### Interest expense, net

### Three Months Ended June 30, 2014 vs. 2013

Interest expense, net for the second quarter of 2014 was $15.3 million as compared to the second quarter of 2013 of $11.1 million. The increase was primarily due to higher overall debt levels driven by funding requirements for the acquisition of Epax and increased working capital requirements.

### Six Months Ended June 30, 2014 vs. 2013

Interest expense, net for the first half of 2014 was $28.8 million as compared to the first half of 2013 of $21.6 million. The increase is consistent with the description provided for the three months ended June 30, 2014.

#### Corporate special (charges) income

### Three Months Ended June 30, 2014 vs. 2013

#### Restructuring and other charges (income)

*(in Millions)*

|  | Three Months Ended June 30 2014 | 2013 | Six Months Ended June 30 2014 | 2013 |
| --- | ---: | ---: | ---: | ---: |
| Restructuring charges and asset disposals | $1.4 | $3.8 | $6.7 | $11.6 |
| Other charges (income), net | 1.3 | 2.1 | 2.7 | 3.6 |
| Total restructuring and other charges | $2.7 | $5.9 | $9.4 | $15.2 |

Restructuring and asset disposal charges in 2014 of $1.4 million were primarily associated with the announced Health and Nutrition restructuring. Other charges (income) net in 2014 of $1.3 million were primarily related to corporate environmental charges.

Restructuring and asset disposal charges in 2013 of $3.8 million were primarily associated with the previously announced Lithium restructuring. Other charges (income) net in 2013 of $2.1 million were primarily related to corporate environmental charges.

The liabilities associated with the restructuring charges listed above are also included within Note 7 to our condensed consolidated financial statements included in this Form 10-Q. We believe the restructuring plans implemented are on schedule and the benefits and savings either have been or will be achieved.

#### Non-operating pension and postretirement charges

The charge for the three months ended June 30, 2014 was $2.7 million compared to $11.6 million for the three months ended June 30, 2013. The decrease was primarily the result of lower amortization of actuarial losses of $9.6 million attributable to a lengthening of the average remaining service period used for amortization purposes as a result of a completed actuarial study indicating overall decreases in retirement and termination activity.

#### Business separation costs

Charges are associated with our announced plan to separate into two independent public companies. See Note 3 to our condensed consolidated financial statements included in this Form 10-Q for more detail on the business separation costs.

#### Acquisition related charges

Charges for the three months ended June 30, 2014, represented the final amortization of inventory fair value step-up associated with our Epax acquisition within our FMC Health and Nutrition segment. No such charges existed for the three months ended June 30, 2013.

### Six Months Ended June 30, 2014 vs. 2013

#### Restructuring and other charges (income)

Restructuring and asset disposal charges in 2014 of $6.7 million were primarily associated with the announced Health and Nutrition restructuring. Other charges (income) net in 2014 of $2.7 million were primarily related to corporate environmental charges.

Restructuring and asset disposal charges in 2013 of $11.6 million were primarily associated with the previously announced Lithium restructuring. Other charges (income) net in 2013 of $3.6 million were primarily related to corporate environmental charges.

#### Non-operating pension and postretirement charges

The charge for the six months ended June 30, 2014 was $6.9 million compared to $24.3 million for the six months ended June 30, 2013. The decrease was primarily the result of lower amortization of actuarial losses of $19.2 million attributable to a lengthening of the average remaining service period used for amortization purposes as a result of a completed actuarial study regarding the length of participant service.

#### Business separation costs

Charges are associated with our announced plan to separate into two independent public companies. See Note 3 to our condensed consolidated financial statements included in this Form 10-Q for more detail on the business separation costs.

#### Acquisition related charges

Charges for the six months ended June 30, 2014, represented the final amortization of inventory fair value step-up associated with our Epax acquisition within our FMC Health and Nutrition segment. No such charges existed for the six months ended June 30, 2013.

#### Provision for income taxes

### Three Months Ended June 30, 2014 vs. 2013

Provision for income taxes was $41.5 million resulting in an effective tax rate of 24.8 percent compared to a provision of $35.7 million resulting in an effective tax rate of 23.0 percent for the three months ended June 30, 2014 and 2013, respectively. The increase in the effective tax rate was primarily the result of the change in the mix of domestic income compared to income earned outside of the U.S. A larger portion of our earnings were earned by our domestic operations which generally has a higher tax rate than that of our foreign operations.

### Six Months Ended June 30, 2014 vs. 2013

Provision for income taxes was $80.8 million resulting in an effective tax rate of 24.7 percent compared to a provision of $81.1 million resulting in an effective tax rate of 23.9 percent for the six months ended June 30, 2014 and 2013, respectively. The increase in the effective tax rate for the six months is consistent with the description provided above on the three months ended June 30, 2014.

#### Discontinued operations, net of income taxes

Our discontinued operations represent our discontinued FMC Peroxygens business results as well as adjustments to retained liabilities from previous discontinued operations. The primary liabilities retained include environmental liabilities, other postretirement benefit liabilities, self-insurance, long-term obligations related to legal proceedings and historical restructuring activities. For more information on our Discontinued operations, net of income taxes, see Note 10 to our condensed consolidated financial statements included in this Form 10-Q.

### Three Months Ended June 30, 2014 vs. 2013

Discontinued operations, net of income taxes represented a loss of $12.6 million for the three months ended June 30, 2014, compared to a gain of $1.5 million for the three months ended June 30, 2013. The loss for 2014 was driven by an increase in provisions for environmental liabilities and legal reserves. The gain recognized in 2013 was due to a $13.9 million insurance recovery related to previously discontinued operations legal matters.

### Six Months Ended June 30, 2014 vs. 2013

Discontinued operations, net of income taxes represented a loss of $62.7 million for the six months ended June 30, 2014, compared to a loss of $1.7 million for the six months ended June 30, 2013. The increase was driven by the completed divestiture of our FMC Peroxygens business which resulted in an after-tax loss of $40.0 million.

#### Net income attributable to FMC stockholders

### Three Months Ended June 30, 2014 vs. 2013

Net income attributable to FMC stockholders decreased to $109.1 million for the three months ended June 30, 2014, from $118.0 million for the three months ended June 30, 2013. The decrease was driven by higher costs from our discontinued operations and business separation costs. Partially offsetting these costs are higher segment operating profit and lower non-operating pension and postretirement charges.

### Six Months Ended June 30, 2014 vs. 2013

Net income attributable to FMC stockholders decreased to $174.7 million for the six months ended June 30, 2014, from $248.9 million for the six months ended June 30, 2013. The decrease was due to reduced segment operating profits in our FMC Agricultural Solutions segment, the loss on the sale of our discontinued FMC Peroxygens business, and the costs associated with our recently announced business separation. Partially offsetting these costs are lower non-operating pension and postretirement charges.

### LIQUIDITY AND CAPITAL RESOURCES

Cash and cash equivalents at June 30, 2014 and December 31, 2013, were $114.4 million and $123.2 million, respectively. Of the cash and cash equivalents balance at June 30, 2014, $101.6 million were held by our foreign subsidiaries. Our intent is to reinvest permanently the earnings of our foreign subsidiaries and therefore we have not recorded taxes that would be payable if we repatriated these earnings.

At June 30, 2014, we had total debt of $1,697.9 million as compared to $1,851.9 million at December 31, 2013. Total debt included $1,153.7 million and $1,154.1 million of long-term debt (excluding current portions of $18.9 million and $34.7 million) at June 30, 2014 and December 31, 2013, respectively. Short-term debt, which consists primarily of borrowings under our commercial paper program, decreased from $663.1 million at December 31, 2013 to $525.3 million at June 30, 2014. Our commercial paper program allows us to borrow at rates generally more favorable than those available under our credit facility. We have used proceeds from the commercial paper program for general corporate purposes. At June 30, 2014, the average effective interest rate on these borrowings was 0.33%.

### Statement of Cash Flows

*Cash provided by operating activities was $148.5 million and $248.0 million for the six months ended June 30, 2014 and 2013, respectively.*

The table below presents the components of net cash provided (required) by operating activities.

*(in Millions)*

| 2014 | Six Months Ended June 30 | 2013 |
| --- | ---: | ---: |
| Income from continuing operations before equity in (earnings) loss of affiliates, interest income and expense and income taxes | $356.2 | $361.0 |
| Significant non-cash expenses (1) | 91.6 | 103.5 |
| **Operating income before non-cash expenses (Non-GAAP)** | **$447.8** | **$464.5** |
| Change in trade receivables (2) | (15.2) | 29.9 |
| Change in inventories (3) | (50.2) | 10.4 |
| Change in accounts payable | (52.3) | (71.7) |
| Change in accrued rebates (4) | 146.0 | 178.8 |
| Change in advance payments from customers (5) | (174.9) | (135.1) |
| Change in all other operating assets and liabilities (6) | (16.9) | (58.2) |
| Restructuring and other spending (7) | (4.6) | (6.5) |
| Environmental spending, continuing, net of recoveries (8) | (5.1) | (2.9) |
| Pension and other postretirement benefit contributions (9) | (45.2) | (43.0) |
| **Cash basis operating income (Non-GAAP)** | **$229.4** | **$366.2** |
| Interest payments | (19.6) | (22.4) |
| Tax payments (10) | (57.3) | (89.5) |
| Excess tax benefits from share-based compensation | (4.0) | (6.3) |
| **Cash provided (required) by operating activities** | **$148.5** | **$248.0** |

(1) Represents the sum of depreciation, amortization, non-cash asset write downs, share-based compensation, and pension charges.

(2) Overall, the use of cash in 2014 for trade receivables is due to increases in our FMC Health and Nutrition business as well as in our FMC Agricultural Solutions' business in Brazil where terms are significantly longer than the rest of our businesses. The change from 2013 to 2014 is also due timing of collections.

(3) The change in inventory from 2013 to 2014 resulted in a use of cash primarily due to an inventory build to fulfill projected demand in the second half of 2014 in FMC Agricultural Solutions and FMC Health and Nutrition.

(4) These rebates are associated with our FMC Agricultural Solutions segment, primarily in North America and Brazil. The decrease from 2013 to 2014 is primarily associated with the mix in sales eligible for rebates and incentives in 2014 compared to 2013 as well as timing of payment of rebates.

(5) The advance payments from customers represent advances from our FMC Agricultural Solutions segment customers. The use of cash for each year presented is consistent with our sales increases year over each year.

(6) Changes in all periods presented primarily represent timing of payments associated with all other operating assets and liabilities, including guarantees issued to our vendors under our vendor finance program.

(7) See Note 7 in our condensed consolidated financial statements included in this Form 10-Q for further details.

(8) Included in our results are environmental charges for environmental remediation at our operating sites of for the three and six months ended June 30, 2014 of $1.3 million and $2.7 million, respectively and $1.0 million and $2.0 million, respectively for the three and six months ended June 30, 2013. The amounts in 2014 will be spent in periods beyond second quarter 2014. The amounts in this row represent environmental remediation spending at our operating sites which were recorded against pre-existing reserves, net of recoveries.

(9) Amounts include voluntary contributions to our U.S. defined benefit plan of $32.0 million and $27.0 million, respectively for the six months ended June 30, 2014 and 2013.

(10) The reduction in tax payments from 2013 to 2014 is due to December 31, 2013 domestic prepaid tax balance that was utilized in the first quarter of 2014, thereby reducing tax payments for the first half 2014.

*Cash required by operating activities of discontinued operations was $33.4 million and $14.9 million for the six months ended June 30, 2014 and 2013, respectively.*

The increase in cash required by operating activities of discontinued operations in 2014 is due the spending associated with divestiture of our FMC Peroxygens business which was accrued for in first quarter of 2014 as well as increased spending associated with our other discontinued reserves which primarily includes retained legal obligations. This increased spending was slightly offset by reduced net spending associated with discontinued environmental remediation sites.

*Cash required by investing activities of continuing operations was $125.3 million and $101.4 million for the six months ended June 30, 2014 and 2013, respectively.*

The increase in spending during the six months ended June 30, 2014, as compared to the same period in 2013 was primarily due to higher capital expenditures in our FMC Health and Nutrition segment.

*Cash provided (required) by investing activities of discontinued operations was $200.0 million and $(11.3) million for the six months ended June 30, 2014 and 2013, respectively.*

Cash provided by investing activities of discontinued operations in 2014 is directly associated with the sale of our FMC Peroxygens business which was completed on February 28, 2014. For more information see Note 10 in our condensed consolidated financial statements included in this Form 10-Q.

*Cash required by financing activities was $198.2 million and $119.1 million for the six months ended June 30, 2014 and 2013, respectively.*

The change period over period in financing activities is primarily due the repayment of debt in 2014 compared to borrowings in 2013. In 2013, increased borrowings were approximately $107 million compared to repayments in 2014 of $155 million. Additionally during the six months ended 2013 we paid approximately $116 million in share repurchases and $87 million to noncontrolling interests (primarily to acquire additional ownership in our FMC Wyoming business) compared to approximately $16 million in combined payments in 2014.

### Other potential liquidity needs

On March 10, 2014, we announced a plan to separate into two independent public companies. One company initially referred to as “New FMC,” will contain our FMC Agricultural Solutions and FMC Health and Nutrition segments, while the other company, "FMC Minerals", will be comprised of our FMC Minerals segment. “New FMC” will be renamed "FMC Corporation" subsequent to the separation.

We are currently in the process of evaluating the form and structure to separate FMC Corporation into two separate independent companies. We expect the separation, which remains subject to final board approval and other customary conditions, to take the form of a tax-free distribution of shares to existing FMC Corporation shareholders. For the three and six months ended June 30, 2014, $13.8 million and $16.8 million, respectively in expense was recognized related to this transaction and is included within "Business separation costs" on our condensed consolidated statement of income. These costs were primarily related to professional fees associated with separation activities within finance and legal functions. We expect the cost to complete the separation will approximate $100 million to $130 million.

Our cash needs for 2014 include operating cash requirements, capital expenditures, scheduled mandatory payments of long-term debt, dividend payments, share repurchases, contributions to our pension plans, environmental and asset retirement obligation spending and restructuring. We plan to meet our liquidity needs through available cash, cash generated from operations, commercial paper issuances and borrowings under our committed revolving credit facility. At June 30, 2014, our remaining borrowing capacity under our credit facility was $913.4 million (which includes borrowings under our commercial paper program).

Projected 2014 capital expenditures as well as expenditures related to contract manufacturers are expected to be consistent with 2013, as increased capital expenditures in FMC Agricultural Solutions and FMC Minerals will be offset by a reduction in FMC Health and Nutrition.

Projected 2014 spending includes approximately $35 million of net environmental remediation spending. This spending does not include expected spending of approximately $10 million in 2014 on capital projects relating to environmental control facilities. Also, we expect to spend approximately $30 million in 2014 for environmental compliance costs, which we will include as a component of costs of sales and services in our condensed consolidated statements of income since these amounts are not covered by established reserves. Capital spending to expand, maintain or replace equipment at our production facilities may trigger requirements for upgrading our environmental controls, which may increase our spending for environmental controls over the foregoing projections.

In order to reduce future funding volatility in our U.S. qualified defined benefit pension plan (U.S. Plan), we have made voluntary contributions through June 30, 2014 and 2013 of $32.0 million and $27.0 million, respectively. We expect to make approximately $50 million in voluntary cash contributions to our U.S. defined benefit pension plan during 2014. These contributions are in excess of the minimum requirements. We made voluntary contributions of $40 million in 2013. We do not believe that these projected contributions will have a material negative impact on our current and future liquidity needs. However, any volatility of interest rates or negative equity returns may require greater contributions to the U.S. Plan in the future.

For the six months ended June 30, 2014 and 2013, we paid $38.0 million and $37.1 million, respectively, in dividends declared in previous periods. On July 17, 2014, we paid dividends totaling $20.1 million to our shareholders of record as of June 30, 2014. This amount is included in “Accrued and other liabilities” on the condensed consolidated balance sheet as of June 30, 2014.

During the six months ended June 30, 2014, we did not repurchase any shares under the publicly announced repurchase program. At June 30, 2014, $250.0 million remained unused under our Board-authorized repurchase program. This repurchase program does not include a specific timetable or price targets and may be suspended or terminated at any time. Shares may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market conditions and other factors. We also reacquire shares from time to time from employees in connection with the vesting, exercise and forfeiture of awards under our equity compensation plans.

We have various subsidiaries that conduct business within Argentina, primarily in our FMC Agricultural Solutions and FMC Minerals segments. At June 30, 2014 we had $56.4 million of outstanding receivables due from the Argentina government which primarily represent export tax and valued added tax receivables. As with all outstanding receivable balances we continually review recoverability by analyzing historical experience, current collection trends and regional business and political factors among other factors. We have further analyzed the recoverability of our outstanding receivables from the Argentina government in light of the current economic and political environment within Argentina, including the recent credit downgrades of local and federal governments and the recent US Supreme Court ruling regarding hold-out bond creditor payments. Based on our analysis of the impact of economic conditions in Argentina on our receivables, at this time, we believe the outstanding receivables to be recoverable.

On July 31, 2014, the Argentina Government defaulted on some of its debt obligations. At this time, we are not able to reasonably estimate the financial statement impact of this event, if any.

### Commitments and Contingencies

See Note 18 to our condensed consolidated financial statements included in this Form 10-Q.

### Contractual Commitments

Information related to our contractual commitments at December 31, 2013 can be found in a table included within Part II, Item 7 of our 2013 Form 10-K. There have been no material changes to our contractual commitments during the six months ended June 30, 2014.

### Climate Change

A detailed discussion related to climate change can be found in Part II, Item 7 of our 2013 Form 10-K. There have been no material changes related to climate change from the information reported in our 2013 10-K.

### Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

### Fair-Value Measurements

See Note 17 to our condensed consolidated financial statements in this Form 10-Q for additional discussion surrounding our fair value measurements.

### DERIVATIVE FINANCIAL INSTRUMENTS AND MARKET RISKS

Our earnings, cash flows, and financial position are exposed to market risks relating to fluctuations in commodity prices, interest rates and foreign currency exchange rates. Our policy is to minimize exposure to our cash flow over time caused by changes in commodity, interest and currency exchange rates. To accomplish this, we have implemented a controlled program of risk management consisting of appropriate derivative contracts entered into with major financial institutions.

The analysis below presents the sensitivity of the market value of our financial instruments to selected changes in market rates and prices. The range of changes chosen reflects our view of changes that are reasonably possible over a one-year period. Market-value estimates are based on the present value of projected future cash flows considering the market rates and prices chosen.

At June 30, 2014, our financial instrument position was a net liability of $7.2 million compared to a net liability of $6.4 million at December 31, 2013. The change in the net financial instrument position was primarily due to larger unrealized losses in our commodity and foreign exchange portfolios.

Since our risk management programs are generally highly effective, the potential loss in value for each risk management portfolio described below would be largely offset by changes in the value of the underlying exposure.

### Commodity Price Risk

Energy costs are approximately seven percent of our cost of sales and services and are diversified among coal, electricity, and natural gas. We attempt to mitigate our exposure to increasing energy costs by hedging the cost of future deliveries of natural gas and by entering into fixed-price contracts for the purchase of coal and fuel oil. To analyze the effect of changing energy prices, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in energy market prices from their levels at June 30, 2014 and December 31, 2013, with all other variables (including interest rates) held constant.

*(in Millions)*

|  | Net Asset / (Liability) Position | Hedged energy exposure vs. Energy market pricing 10% Increase | 10% Decrease |
| --- | ---: | ---: | ---: |
| **Net asset/(liability) position at June 30, 2014** | $0.7 | $3.5 | $(2.0) |
| **Net asset/(liability) position at December 31, 2013** | $0.1 | $3.0 | $(2.7) |

Our FMC Agricultural Solutions segment enters into contracts with certain customers in Brazil to exchange our products for future physical delivery of soybeans. To mitigate the price risk associated with these barter contracts, we enter into offsetting derivatives to hedge our exposure. As of June 30, 2014 and December 31, 2013 we had no outstanding soybean derivative contracts.

### Foreign Currency Exchange Rate Risk

The primary currencies for which we have exchange rate exposure are the U.S. dollar versus the euro, the U.S. dollar versus the Chinese yuan and the U.S. dollar versus the Brazilian real. Foreign currency debt and foreign exchange forward contracts are used in countries where we do business, thereby reducing our net asset exposure. Foreign exchange forward contracts are also used to hedge firm and highly anticipated foreign currency cash flows.

To analyze the effects of changing foreign currency rates, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in the foreign currency exchange rates from their levels at June 30, 2014 and December 31, 2013, with all other variables (including interest rates) held constant.

*(in Millions)*

|  | Net Asset / (Liability) Position | Hedged currency vs. Functional currency 10% Strengthening | 10% Weakening |
| --- | ---: | ---: | ---: |
| **Net asset/(liability) position at June 30, 2014** | $(7.9) | $21.5 | $(36.4) |
| **Net asset/(liability) position at December 31, 2013** | $(6.5) | $9.1 | $(21.0) |

### Interest Rate Risk

One of the strategies that we can use to manage interest rate exposure is to enter into interest rate swap agreements. In these agreements, we agree to exchange, at specified intervals, the difference between fixed and variable interest amounts calculated on an agreed-upon notional principal amount. As of June 30, 2014 and December 31, 2013, we had no interest rate swap agreements.

Our debt portfolio, at June 30, 2014, is composed of 69 percent fixed-rate debt and 31 percent variable-rate debt. The variable-rate component of our debt portfolio principally consists of borrowings under our Credit Facility, commercial paper program, variable-rate industrial and pollution control revenue bonds, and amounts outstanding under foreign subsidiary credit lines. Changes in interest rates affect different portions of our variable-rate debt portfolio in different ways.

Based on the variable-rate debt in our debt portfolio at June 30, 2014, a one percentage point increase in interest rates then in effect would have increased gross interest expense by $5.2 million and a one percentage point decrease in interest rates then in effect would have decreased gross interest expense by $1.9 million for the six months of June 30, 2014.

## Market risk

As filed, 207 characters.

The information required by this item is provided in “Derivative Financial Instruments and Market Risks,” under ITEM 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations.

## Controls and procedures

As filed, 3,478 characters.

(a) Evaluation of disclosure controls and procedures. Based on management’s evaluation (with the participation of the Company’s Chief Executive Officer and Chief Financial Officer), the Chief Executive Officer and Chief Financial Officer have concluded that, as of June 30, 2014, the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) are effective to provide reasonable assurance that information required to be disclosed by the Company in reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

(b) Change in Internal Controls. There have been no changes in internal control over financial reporting that occurred during the quarter ended June 30, 2014, that materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

### REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors and Shareholders

FMC Corporation:

We have reviewed the condensed consolidated balance sheet of FMC Corporation and subsidiaries as of June 30, 2014, the related condensed consolidated statements of income and comprehensive income for the three-month and six-month periods ended June 30, 2014 and 2013, and the related condensed consolidated statements of cash flows for the six-month periods ended June 30, 2014 and 2013. These condensed consolidated financial statements are the responsibility of the Company’s management.

We conducted our reviews in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our reviews, we are not aware of any material modifications that should be made to the condensed consolidated financial statements referred to above for them to be in conformity with U.S. generally accepted accounting principles.

We have previously audited, in accordance with standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet of FMC Corporation and subsidiaries as of December 31, 2013, and the related consolidated statements of income, comprehensive income, cash flows, and changes in equity for the year then ended (not presented herein); and in our report dated February 18, 2014, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2013, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

**/s/** KPMG LLP

Philadelphia, Pennsylvania

August 1, 2014

## Risk factors

As filed, 500 characters.

In addition to the other information set forth in this Form 10-Q, you should carefully consider the factors discussed in Part 1, Item 1A "Risk Factors" of our 2013 Form 10-K. The risks described in our Form 10-K are not the only risks that we face. Additional risks not presently known to us or that we do not currently consider significant may also have an adverse effect on us. If any of the risks actually occur, our business, results of operations, cash flows or financial condition could suffer.

Filed Aug 1, 2014.
Source: SEC EDGAR, the filing index for accession 0000037785-14-000035. Last ingested by Listed: Nov 13, 2026, 16:31 ET. No prices; not investment advice.
